Investigation of the Mechanism by Which Statins Inhibit Growth of Staphylococcal Bacteria and Their Synergistic Effects when Combined with Antimicrobials
Des Moines University faculty, staff, and students.
Kelsey Randel, MBS’15
Des Moines University, Des Moines, IA
- Describe the synergistic antimicrobial effects of HMG-CoA reductase inhibitors on the growth of S. aureus when used in combination with aminoglycosides.
- Compare and contrast the antimicrobial effect of fungal derived statins with synthetic stains on S. aureus growth.
- Diagram the dose dependent antimicrobial effect, of HMG-CoA reductase inhibitors on S. aureus growth, when the concentration of an antimicrobial is held constant.
Continuing Education Credit
- AOA: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) and approves this activity for 1.0 hour of Category 2-A CME credit(s).
- Other: Attendees will be awarded 1.0 hour of continuing education credit.
Educational grants are not being accepted for this activity.
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content for this program and the selection of speakers are responsibilities of the program director. Firms providing financial support did not have input in these areas.
- 1.00 AOA Category 2A
- 1.00 CE Contact Hour(s)